A new FTC settlement with CVS Caremark could lower prescription costs for some Georgia patients and save consumers billions over the next decade.
Express Scripts, the contractor that manages the TRICARE pharmacy program, also operates its own mail-order pharmacies that ...
Senators raised concerns about the potential anti-competitive tactics of the military’s Tricare pharmacy program contractor, ...
9don MSN
Independent pharmacies accuse Prime Therapeutics of price-fixing scheme with Express Scripts
Nearly 5,000 independent pharmacies have filed an antitrust and breach-of-contract lawsuit against Prime Therapeutics, LLC, ...
June 12 (Reuters) - Cigna's (CI.N), opens new tab pharmacy benefits services unit Express Scripts requested on Friday that a federal court strike down a Tennessee state law that it says would ...
WASHINGTON — Sen. Elizabeth Warren, D-Mass., urged the Defense Department to audit Express Scripts to determine if the pharmacy benefit manager is overcharging for prescriptions and steering military ...
Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...
The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...
The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...
The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.
Add Yahoo as a preferred source to see more of our stories on Google. The court battle continues between pharmacy benefit manager Express Scripts and a class action lawsuit filed on behalf of Martella ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results